Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 March 2019 | Story Eugene Seegers | Photo Eugene Seegers
Leading women honoured at faculty opening
Rev Martin Laubscher pictured with Thandeka Khulu, Oarabetse Morokane, Lunette Visser, and Trunette Sevenster, who participated in the worship service.

At its recent opening, the Faculty of Theology and Religion conferred the inaugural Letsema Award on Dr Ellen Vuyiswa Blekie, a medical doctor known for her sterling work in her local community in Thaba Nchu, as well as on the various church councils and committees on which she still serves at the age of 87. Dr Gideon van der Watt, director of the “Partners in Mission” unit of the Dutch Reformed Church in the Free State, presented the award to Dr Blekie on behalf of the faculty.

The theme of the morning’s proceedings was: The church and violence against women and children. This theme was not only borne out by the worship service presented by Rev Martin Laubscher, but also by each of his participants. First, a popular song from 1987, My Name is Luka, by Suzanne Vega, was recited in spoken-word form. The song deals with themes of physical and emotional abuse, as well as being kept silent as a victim. Next, the Paulette Kelly poem I Got Flowers Today was recited. The final stanza begins with the words “I got flowers today.../Today was a special day — it was the day of my funeral...”

Dr Carin van Schalkwyk, who has been serving the Philippolis community and congregation since 1993, conducted the liturgy. Her chosen passage was 2 Samuel 13, which recounts the events leading up to King David’s son Amnon raping his half-sister Tamar and the subsequent cover-up by the king and his sons. Dr Van Schalkwyk likened the way David of old handled the situation to the modern church’s failure regarding the protection of women and children, stating these vulnerable ones have been failed miserably.

Dr Van Schalkwyk added: “The root of the problem has not been addressed. It requires a rethinking of both preaching and policy, even of theology. All are created in God’s image; what does that mean?”

Concluding, she said, “We need to hear the lament of those affected, and weep with them. I dream of a day when women do not have to think of how to avoid sexual harassment on a daily basis.”


News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept